Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Urs Christen

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Current Pharmaceutical Design|March 18, 2015
An Update on Animal Models of Autoimmune Hepatitis: Are we There Yet?Urs Christen, Edith Hintermann
Cells|November 28, 2019
The Many Roles of Cell Adhesion Molecules in Hepatic FibrosisEdith Hintermann, Urs Christen
Frontiers in Endocrinology|November 16, 2020
Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment ScheduleUrs Christen, Ruta Kimmel
International Reviews of Immunology|June 10, 2014
Pathogen infection as a possible cause for autoimmune hepatitisUrs Christen, Edith Hintermann
Frontiers in Immunology|July 29, 2022
Animal Models for Autoimmune Hepatitis: Are Current Models Good Enough?Urs Christen, Edith Hintermann
Frontiers in Immunology|March 6, 2018
Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease?Urs Christen, Edith Hintermann
Autoimmunity|November 3, 2004
IP-10 and type 1 diabetes: a question of time and locationUrs Christen, Matthias G von Herrath
Advances in Experimental Medicine and Biology|March 5, 2003
Cytokines and chemokines in virus-induced autoimmunityUrs Christen, Matthias G von Herrath
Cellular & Molecular Immunology|January 25, 2011
Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference?Urs Christen, Matthias G von Herrath
Molecular Immunology|March 24, 2004
Induction, acceleration or prevention of autoimmunity by molecular mimicryUrs Christen, Matthias G von Herrath
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Current Pharmaceutical Design|March 18, 2015
An Update on Animal Models of Autoimmune Hepatitis: Are we There Yet?Urs Christen, Edith Hintermann
Cells|November 28, 2019
The Many Roles of Cell Adhesion Molecules in Hepatic FibrosisEdith Hintermann, Urs Christen
Frontiers in Endocrinology|November 16, 2020
Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment ScheduleUrs Christen, Ruta Kimmel
International Reviews of Immunology|June 10, 2014
Pathogen infection as a possible cause for autoimmune hepatitisUrs Christen, Edith Hintermann
Frontiers in Immunology|July 29, 2022
Animal Models for Autoimmune Hepatitis: Are Current Models Good Enough?Urs Christen, Edith Hintermann
Frontiers in Immunology|March 6, 2018
Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease?Urs Christen, Edith Hintermann
Autoimmunity|November 3, 2004
IP-10 and type 1 diabetes: a question of time and locationUrs Christen, Matthias G von Herrath
Advances in Experimental Medicine and Biology|March 5, 2003
Cytokines and chemokines in virus-induced autoimmunityUrs Christen, Matthias G von Herrath
Cellular & Molecular Immunology|January 25, 2011
Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference?Urs Christen, Matthias G von Herrath
Molecular Immunology|March 24, 2004
Induction, acceleration or prevention of autoimmunity by molecular mimicryUrs Christen, Matthias G von Herrath
Pageof 9